Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical and MRI correlation in multiple system atrophy]

K Negoro1, M Morimatsu

  • 1Department of Neurology, Yamaguchi University School of Medicine, Ube, Japan.

No to Shinkei = Brain and Nerve
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.

The pharmacogenomics journal·2015
Same author

Case of leiomyomatosis peritonealis disseminata treated with a gn-rh analog.

Oncology reports·2011
Same author

In-vitro cytotoxicity in ovarian-cancer of low-dose continuous exposure to microtubule inhibitors (Paclitaxel taxotere) combined with Cisplatin.

Oncology reports·2011
Same author

Metastases observed autopsy in 70 women with ovarian-cancer - relationship to treatment.

Oncology reports·2011
Same author

Neural cell adhesion molecule expression in thyroid cancer.

Oncology reports·2011
Same author

A role of matrix metalloproteinases produced by glioma-cells.

International journal of oncology·2011
Same journal

[Evaluation of cerebral hemodynamics in a patient with middle cerebral artery stenosis by flow-sensitive alternating inversion recovery technique].

No to shinkei = Brain and nerve·2007
Same journal

[Ruptured aneurysm of distal posterior inferior cerebellar artery located at caudal loop].

No to shinkei = Brain and nerve·2007
Same journal

[Bilateral cerebellar infarction caused by intracranial dissection of the vertebral artery after long periods of "Shiatsu"].

No to shinkei = Brain and nerve·2007
Same journal

[Depression following intracerebral hemorrhage and the evaluation of cerebral blood flow by single photon emission tomography].

No to shinkei = Brain and nerve·2007
Same journal

[Study on the distribution of collagen fibers in the bifurcating area of cerebral arterioles of Wistar rats].

No to shinkei = Brain and nerve·2007
Same journal

[Newer antiepileptic drugs].

No to shinkei = Brain and nerve·2007
See all related articles

Magnetic resonance imaging (MRI) reveals putaminal abnormalities in multiple system atrophy (MSA) patients. These MRI findings are useful for evaluating parkinsonism in MSA, correlating with disease duration and severity.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Context:

  • Multiple System Atrophy (MSA) is a neurodegenerative disorder.
  • Clinical subtypes include olivo-pontocerebellar atrophy (OPCA), Shy-Drager syndrome (SDS), and striatonigral degeneration (SND).
  • Accurate diagnosis and evaluation of MSA subtypes are crucial.

Purpose:

  • To investigate the utility of magnetic resonance imaging (MRI) in characterizing the neuroanatomical changes in patients with clinically diagnosed MSA.
  • To correlate MRI findings with clinical features such as cerebellar ataxia and parkinsonism.

Summary:

  • MRI studies of 11 MSA patients (5 OPCA, 2 SDS, 4 SND) revealed distinct patterns of atrophy.
  • Posterolateral putaminal abnormalities (low T2 signal, high PD signal) were observed in SDS and SND patients.

Related Experiment Videos

  • Putaminal low T2 signals correlated positively with parkinsonism duration and severity, suggesting MRI's value in evaluating this symptom in MSA.

    • Impact:

    • MRI findings, particularly putaminal signal changes, can aid in the diagnostic evaluation of parkinsonism in MSA.
    • This study highlights the role of neuroimaging in differentiating MSA subtypes and assessing disease progression.